Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction

The Journal of Immunology : Official Journal of the American Association of Immunologists
Tania BordaLeonor Sterin-Borda

Abstract

We demonstrated the presence of circulating Abs from schizophrenic patients able to interact with cerebral frontal cortex-activating muscarinic acetylcholine receptors (mAChR). Sera and purified IgG from 21 paranoid schizophrenic and 25 age-matched normal subjects were studied by indirect immunofluorescence, flow cytometry, immunoblotting, dot blot, ELISA, and radioligand competition assays. Rat cerebral frontal cortex membranes and/or a synthetic peptide, with an amino acid sequence identical with that of human M(1) mAChR, were used as Ags. By indirect immunofluorescence and flow cytometry procedures, we proved that serum-purified IgG fraction from schizophrenic patients reacted to neural cell surfaces from rat cerebral frontal cortex. The same Abs were able to inhibit the binding of the specific M(1) mAChR radioligand [(3)H]pirenzepine. Immunoblotting experiments showed that IgG from schizophrenic patients revealed a band with a molecular mass coincident to that labeled by an anti-M(1) mAChR Ab. Using synthetic peptide for dot blot and ELISA, we demonstrated that these Abs reacted against the second extracellular loop of human cerebral M(1) mAChR. Also, the corresponding affinity-purified antipeptide Ab displayed an agonistic...Continue Reading

References

Feb 1, 1978·The American Journal of Psychiatry·A Carlsson
Jan 1, 1991·Annals of the New York Academy of Sciences·M ShinitzkyA Elizur
Feb 15, 1991·Biological Psychiatry·S ShimaY Tokunaga
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D M WeinerM R Brann
Mar 15, 1989·Biological Psychiatry·R G HeathC E O'Neil
Jan 1, 1987·Annals of the New York Academy of Sciences·R GanguliU Ragu
Jan 1, 1967·Archives of General Psychiatry·R G HeathJ I Liljekvist
Jan 1, 1994·Neuropsychobiology·S NoyN Laor
Dec 1, 1994·Schizophrenia Research·A E HennebergS Ruffert
Nov 15, 1994·European Journal of Pharmacology·S H ZornD R Liston
Jan 1, 1993·European Archives of Psychiatry and Clinical Neuroscience·A E HennebergH H Kornhuber
Oct 1, 1995·Acta Psychiatrica Scandinavica·K N ChengappaR Ganguli
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A I Levey
Aug 29, 1997·Schizophrenia Research·M MaesH Y Meltzer
Jun 18, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D Hinze-SelchT Pollmächer
Feb 3, 1999·European Archives of Psychiatry and Clinical Neuroscience·M J SchwarzM Ackenheil
Mar 9, 1999·Life Sciences·F P BymasterA Fink-Jensen
Jul 13, 1999·International Journal of Cardiology·E BordaL Sterin-Borda
Nov 6, 2001·Journal of Neuroimmunology·A Zameer, S A Hoffman

❮ Previous
Next ❯

Citations

Dec 24, 2008·Expert Review of Neurotherapeutics·Donald P Rogers, Carroll-Ann W Goldsmith
Jan 29, 2010·European Archives of Psychiatry and Clinical Neuroscience·Johann SteinerBernhard Bogerts
Jun 29, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Johann SteinerAye-Mu Myint
Jun 20, 2006·Acta Neuropathologica·Johann SteinerBernhard Bogerts
Dec 6, 2006·Molecular Psychiatry·T J RaedlerB Dean
May 28, 2008·Pharmacotherapy·Carroll-Ann W Goldsmith, Donald P Rogers
Oct 24, 2007·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G Miller Jonakait
Oct 20, 2009·The International Journal of Neuropsychopharmacology·Sabrina GanzinelliLeonor Sterin-Borda
Apr 21, 2016·Antibodies·Carolin HoffmannPilar Martinez-Martinez
Dec 17, 2009·Psychopharmacology·Morgane ThomsenS Barak Caine
Jan 28, 2014·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Annya M Smyth, Stephen M Lawrie
Jul 28, 2019·The Australian and New Zealand Journal of Psychiatry·Alexander E RyanJudith M Greer
Sep 29, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Silvia ReinaEnri Borda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here